TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CTMX

CytomX Therapeutics Inc

Healthcare · Biotechnology

2.70$ -1.1% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

CytomX Therapeutics Inc (CTMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 381 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CTMX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
221 202 185 159 139 121 98 175 158 152 359 381
201 183 167 143 124 107 87 165 149 144 353 373
26 17 36 43 41 38 48 49 34 13 29 17
194 175 150 137 118 101 80 158 144 137 347 330
2.4 3.4 13 2.8 3.4 3.1 2.0 1.9 1.6 2.0 0.6 37
0.0 – – – – – – – – – – –
0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
0.8 0.7 0.7 0.7 0.6 0.6 0.5 0.5 0.5 0.4 0.4 0.4
272 249 216 190 162 121 73 55 51 53 39 79
147 156 145 143 119 86 50 39 41 47 34 40
4.5 4.6 4.7 4.9 5.0 5.1 5.3 5.4 5.6 4.2 2.9 1.5
1.7 1.5 2.0 0.6 1.4 1.1 0.3 0.2 0.6 1.3 1.4 1.9
-51 -47 -32 -31 -23 -0.5 25 120 107 99 320 302
-724 -723 -710 -716 -710 -692 -668 -668 -682 -712 -730 -751
81 67 83 85 85 80 87 129 165 170 177 219

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?